Processa Pharmaceuticals's market cap is currently $2.51M. The company's EPS TTM is $-5.017; its P/E ratio is ―; Processa Pharmaceuticals is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.92. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -222.00	$ -27.53M	$ -12.13M	$ -15.14M	$ -877.90K
Operating Income	$ -11.46M	$ -27.53M	$ -12.13M	$ -15.14M	$ -3.94M
EBITDA	$ -11.46M	$ -19.47M	$ -11.08M	$ -5.63M	$ -3.05M
Net Income	$ -11.12M	$ -54.85M	$ -11.43M	$ -14.41M	$ -3.36M
Balance Sheet
Cash & Short-Term Investments	$ 4.71M	$ 6.50M	$ 16.50M	$ 15.42M	$ 691.54K
Total Assets	$ 5.79M	$ 8.62M	$ 26.46M	$ 25.21M	$ 10.88M
Total Debt	$ 150.55K	$ 229.45K	$ 78.46K	$ 328.12K	$ 1.03M
Net Debt	$ -4.56M	$ -6.27M	$ -16.42M	$ -15.09M	$ 336.35K
Total Liabilities	$ 797.48K	$ 1.15M	$ 978.40K	$ 2.27M	$ 2.87M
Stockholders' Equity	$ 4.99M	$ 7.47M	$ 25.49M	$ 22.94M	$ 8.01M
Cash Flow
Free Cash Flow	$ -8.07M	$ -9.61M	$ -8.72M	$ -3.14M	$ -2.75M
Operating Cash Flow	$ -8.06M	$ -9.61M	$ -8.72M	$ -3.14M	$ -2.75M
Investing Cash Flow	$ -2.78K	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 6.27M	$ -388.84K	$ 9.80M	$ 17.87M	$ 1.70M

Currency in USD

Processa Pharmaceuticals Earnings and Revenue History

Income Statement >

Processa Pharmaceuticals Debt to Assets

Balance Sheet >

Processa Pharmaceuticals Cash Flow

Cash Flow >

Processa Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing